AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35365604 — intervention group
Group type: COMPARATOR
Intervention: High neighborhood socioeconomic status (nSES)
Number of subjects: 0
Study 35365604 — intervention group
Group type: EXPERIMENTAL
Intervention: nSES and AL
Number of subjects: 0
Study 35365604 — intervention group
Group type: EXPERIMENTAL
Intervention: nSES
Number of subjects: 0
Study 33782383 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS)
Number of subjects: 9
Study 33782383 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label stimulation with cognitive behavioural therapy (CBT)
Number of subjects: 9
Study 33782383 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioural therapy (CBT)
Number of subjects: 9
Study 32571327 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (balance or strength combined with endurance training) for 12 months
Number of subjects: 112
Study 32571327 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned, but implied as no exercise training)
Number of subjects: 112
Study 32669717 — intervention group
Group type: EXPERIMENTAL
Intervention: AAV1/SERCA2a gene therapy (1 × 10^13 DNase-resistant particles)
Number of subjects: 5
Study 32669717 — intervention group
Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 5
Study 34126984 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride interventions (specific types and dosages not provided)
Number of subjects: 0
Study 32446979 — intervention group
Group type: EXPERIMENTAL
Intervention: Xinyue capsule (100 mg panax quinquefolius saponins, three times a day)
Number of subjects: 1054
Study 32446979 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1054
Study 32446979 — intervention group
Group type: EXPERIMENTAL
Intervention: Xinyue capsule
Number of subjects: 1054
Study 36259542 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.RSV.preF vaccine (1 × 10^11 vp for adults, 5 × 10^10 vp for children)
Number of subjects: 48
Study 36259542 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.RSV.preF vaccine
Number of subjects: 48
Study 36259542 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 34610830 — intervention group
Group type: EXPERIMENTAL
Intervention: Atherogenic index of plasma (AIP)
Number of subjects: 10251
Study 34610830 — intervention group
Group type: EXPERIMENTAL
Intervention: AIP
Number of subjects: 10251
Study 35185620 — intervention group
Group type: COMPARATOR
Intervention: NMES
Number of subjects: 15
Study 35185620 — intervention group
Group type: COMPARATOR
Intervention: Exercise
Number of subjects: 15
Study 35185620 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 15
Study 33217865 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic anterior resection (AR)
Number of subjects: 29
Study 33217865 — intervention group
Group type: COMPARATOR
Intervention: Medicine group
Number of subjects: 29
Study 33217865 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall outcomes
Number of subjects: 29
Study 35473351 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-acupoints-space acupuncture (ATAS) administered weekly
Number of subjects: 0
Study 35473351 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 0
Study 35473351 — intervention group
Group type: COMPARATOR
Intervention: Non-acupuncture
Number of subjects: 0
Study 33439693 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab (1,200 mg IV, day 1) plus carboplatin (AUC 5 mg/mL/min IV, day 1) and etoposide (100 mg/m2 IV, days 1-3)
Number of subjects: 403
Study 33439693 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus carboplatin (AUC 5 mg/mL/min IV, day 1) and etoposide (100 mg/m2 IV, days 1-3)
Number of subjects: 403
Study 33439693 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab plus carboplatin/etoposide
Number of subjects: 403
Study 33439693 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus carboplatin/etoposide
Number of subjects: 403
Study 32381845 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25 dihydroxycholecalciferol (1,25 DHC)
Number of subjects: 15
Study 32381845 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 15
Study 35848580 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured physiotherapy along with conventional treatment
Number of subjects: 35
Study 35848580 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 35
Study 34599724 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose-rate brachytherapy (LDR-BT)
Number of subjects: 567
Study 36334130 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuEPO (20 IU/kg body weight) i.v. injections
Number of subjects: 30
Study 36334130 — intervention group
Group type: COMPARATOR
Intervention: Placebo (isotonic saline)
Number of subjects: 30
Study 33515707 — intervention group
Group type: EXPERIMENTAL
Intervention: Qizhitongluo capsule (QZTL)
Number of subjects: 622
Study 33515707 — intervention group
Group type: EXPERIMENTAL
Intervention: Naoxintong (NXT)
Number of subjects: 622
Study 33515707 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 622
Study 33022010 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwifery continuity of care (POPPIE group)
Number of subjects: 334
Study 33022010 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 334
Study 33358148 — intervention group
Group type: EXPERIMENTAL
Intervention: High Intensive Intervention (HI, n = 63)
Number of subjects: 188
Study 33358148 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate Intensive Intervention (MI, n = 62)
Number of subjects: 188
Study 33358148 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Intensive Intervention (LI, n = 63)
Number of subjects: 188
Study 33358148 — intervention group
Group type: EXPERIMENTAL
Intervention: High Intensive Intervention (HI)
Number of subjects: 188
Study 33358148 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate Intensive Intervention (MI)
Number of subjects: 188
Study 33358148 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Intensive Intervention (LI)
Number of subjects: 188
Study 33358148 — intervention group
Group type: COMPARATOR
Intervention: All groups (HI, MI, LI)
Number of subjects: 188
Study 33228097 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching intervention 1 (TI‐1): integrating the concept of contour lines into practical sessions of acrobatic gymnastics
Number of subjects: 238
Study 33228097 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching intervention 2 (TI‐2): theoretical sessions regarding contour lines
Number of subjects: 238
Study 33228097 — intervention group
Group type: COMPARATOR
Intervention: Active control (AC): reading an introductory text about topographic maps
Number of subjects: 238
Study 33228097 — intervention group
Group type: COMPARATOR
Intervention: Passive control 1 (PC‐1)
Number of subjects: 238
Study 33228097 — intervention group
Group type: COMPARATOR
Intervention: Passive control 2 (PC‐2)
Number of subjects: 238
Study 34971975 — intervention group
Group type: EXPERIMENTAL
Intervention: WM updating training
Number of subjects: 73
Study 34971975 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 73
Study 32993142 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustable sit-stand desk
Number of subjects: 60
Study 32993142 — intervention group
Group type: COMPARATOR
Intervention: Traditional furniture (control)
Number of subjects: 60
Study 35282464 — intervention group
Group type: EXPERIMENTAL
Intervention: Time Restricted Eating (TRE)
Number of subjects: 50
Study 35282464 — intervention group
Group type: COMPARATOR
Intervention: Prolonged eating window (Control)
Number of subjects: 50
Study 33143264 — intervention group
Group type: EXPERIMENTAL
Intervention: High-SES menus
Number of subjects: 45
Study 33143264 — intervention group
Group type: COMPARATOR
Intervention: Low-SES menus
Number of subjects: 45
Study 33143264 — intervention group
Group type: EXPERIMENTAL
Intervention: All menus
Number of subjects: 45
Study 34404270 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 328
Study 34404270 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 328
Study 34404270 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 328
Study 32154732 — intervention group
Group type: EXPERIMENTAL
Intervention: Public education messages (three newly developed messages)
Number of subjects: 152
Study 32154732 — intervention group
Group type: COMPARATOR
Intervention: Control (no message)
Number of subjects: 152
Study 35886214 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-world data (RWD) and real-world evidence (RWE)
Number of subjects: 0
Study 35886214 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic health records (EHRs)
Number of subjects: 0
Study 33611899 — intervention group
Group type: EXPERIMENTAL
Intervention: IVUS guided stent implantation in CKD group
Number of subjects: 1443
Study 33611899 — intervention group
Group type: COMPARATOR
Intervention: Angiography guided stent implantation in CKD group
Number of subjects: 1443
Study 33611899 — intervention group
Group type: EXPERIMENTAL
Intervention: IVUS guided stent implantation in non-CKD group
Number of subjects: 1443
Study 33611899 — intervention group
Group type: COMPARATOR
Intervention: Angiography guided stent implantation in non-CKD group
Number of subjects: 1443
Study 36151602 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized dietary counselling on scheduled appointments throughout 6 months of follow-up
Number of subjects: 62
Study 36151602 — intervention group
Group type: COMPARATOR
Intervention: Informative dietary guidelines at baseline
Number of subjects: 62
Study 34325540 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri DSM 17938/ATCC 5289 for 28 days
Number of subjects: 27
Study 34325540 — intervention group
Group type: COMPARATOR
Intervention: Tablets without any bacteria (Control)
Number of subjects: 27
Study 35038254 — intervention group
Group type: EXPERIMENTAL
Intervention: RTD re‐access kit (Composipost, RTD, France, St Egreve) in a conventional hand‐piece driven by an electric motor (Group A)
Number of subjects: 20
Study 35038254 — intervention group
Group type: EXPERIMENTAL
Intervention: Long tapered diamond bur (FG Diamond grit bur, Dentsply Ltd, UK) in an air‐driven high speed turbine (Group B)
Number of subjects: 20
Study 32949786 — intervention group
Group type: EXPERIMENTAL
Intervention: Glecaprevir/pibrentasvir for 8 weeks
Number of subjects: 100
Study 32949786 — intervention group
Group type: EXPERIMENTAL
Intervention: Glecaprevir/pibrentasvir for 12 weeks
Number of subjects: 100
Study 32949786 — intervention group
Group type: EXPERIMENTAL
Intervention: Glecaprevir/pibrentasvir (both durations)
Number of subjects: 100
Study 35804937 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary care-based follow-up
Number of subjects: 402
Study 35804937 — intervention group
Group type: COMPARATOR
Intervention: Specialist-based follow-up
Number of subjects: 402
Study 32576868 — intervention group
Group type: EXPERIMENTAL
Intervention: hsa_circ_0005548
Number of subjects: 6
Study 32576868 — intervention group
Group type: EXPERIMENTAL
Intervention: hsa_circ_0000607
Number of subjects: 6
Study 32576868 — intervention group
Group type: EXPERIMENTAL
Intervention: hsa_circ_0002465
Number of subjects: 6
Study 32576868 — intervention group
Group type: COMPARATOR
Intervention: DE circRNAs
Number of subjects: 6
Study 32576868 — intervention group
Group type: COMPARATOR
Intervention: Bioinformatic analysis
Number of subjects: 6
Study 35397772 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide (160 mg/day)
Number of subjects: 388
Study 35397772 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 388
Study 35397772 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide
Number of subjects: 388
Study 33274772 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy theory-based parental eczema education program
Number of subjects: 136
Study 36108911 — intervention group
Group type: EXPERIMENTAL
Intervention: Florajen3 probiotic
Number of subjects: 109
Study 36108911 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study 34339227 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuing β-lactam treatment after 3 days
Number of subjects: 0
Study 34339227 — intervention group
Group type: COMPARATOR
Intervention: Continuing β-lactam treatment for 5 additional days
Number of subjects: 0
Study 35386854 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine 0.280 mg/kg
Number of subjects: 120
Study 35386854 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine 0.200 mg/kg
Number of subjects: 120
Study 35386854 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine 0.140 mg/kg
Number of subjects: 120
Study 35386854 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine 0.070 mg/kg
Number of subjects: 120
Study 35386854 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine 0.100 mg/kg
Number of subjects: 120
Study 35386854 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 120
Study 33839634 — intervention group
Group type: EXPERIMENTAL
Intervention: Rescuer at the manikin's right side with right hand chest contact (RsRc)
Number of subjects: 60
Study 33839634 — intervention group
Group type: EXPERIMENTAL
Intervention: Rescuer at the manikin's left side with left hand chest contact (LsLc)
Number of subjects: 60
Study 33839634 — intervention group
Group type: EXPERIMENTAL
Intervention: Rescuer at the manikin's left side with right hand chest contact (LsRc)
Number of subjects: 60
Study 33839634 — intervention group
Group type: EXPERIMENTAL
Intervention: Rescuer at the manikin's right side with left hand chest contact (RsLc)
Number of subjects: 60
Study 32406608 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) with 2 mA for 30 min, applied over the supplementary motor area (SMA) and right supraorbital area.
Number of subjects: 21
Study 35894914 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water walk (10-min shower + 20-min walk in cold water)
Number of subjects: 17
Study 35894914 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water sit (10-min shower + 20-min sit in cold water)
Number of subjects: 17
Study 35894914 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive recovery (10-min shower + 20-min passive recovery)
Number of subjects: 17
Study 35894914 — intervention group
Group type: EXPERIMENTAL
Intervention: Active recovery (10-min treadmill walk + 10-min static stretch + 10-min shower)
Number of subjects: 17
Study 35894914 — intervention group
Group type: COMPARATOR
Intervention: All cooldown strategies
Number of subjects: 17
Study 33853413 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe erosion (lemon juice/pH 2.5)
Number of subjects: 20
Study 33853413 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate erosion (grapefruit juice/pH 3.5)
Number of subjects: 20
Study 33853413 — intervention group
Group type: COMPARATOR
Intervention: No erosion (bottled drinking water, control)
Number of subjects: 20
Study 32016926 — intervention group
Group type: EXPERIMENTAL
Intervention: Single incision cholecystectomy
Number of subjects: 975
Study 35898865 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary metastasectomy plus standard medical treatment
Number of subjects: 0
Study 35898865 — intervention group
Group type: COMPARATOR
Intervention: Standard medical treatment plus possible local ablative measures (e.g., SBRT)
Number of subjects: 0
Study 35898865 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life assessments using EORTC QLQ‐C30, QLQ‐CR29 and QLQ‐LC29 questionnaires
Number of subjects: 0
Study 35898865 — intervention group
Group type: EXPERIMENTAL
Intervention: Progression-free survival
Number of subjects: 0
Study 35898865 — intervention group
Group type: EXPERIMENTAL
Intervention: Impact of mutational status
Number of subjects: 0
Study 33170934 — intervention group
Group type: EXPERIMENTAL
Intervention: Azacitidine maintenance (32 mg/m2 per day subcutaneously for 5 days every 28 days for 12 cycles)
Number of subjects: 187
Study 33170934 — intervention group
Group type: EXPERIMENTAL
Intervention: Azacitidine maintenance
Number of subjects: 187
Study 33170934 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 187
Study 35363600 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33992283 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of physical activity guidelines
Number of subjects: 180
Study 33992283 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitude towards physical activity
Number of subjects: 180
Study 33992283 — intervention group
Group type: EXPERIMENTAL
Intervention: Promotion of physical activities in routine practice
Number of subjects: 180
Study 35211746 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent Training (PT)
Number of subjects: 119
Study 35211746 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducational dental toolkit (control)
Number of subjects: 119
Study 33227017 — intervention group
Group type: EXPERIMENTAL
Intervention: Microscopy
Number of subjects: 1870
Study 33227017 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR
Number of subjects: 1870
Study 33227017 — intervention group
Group type: EXPERIMENTAL
Intervention: P. falciparum mono-infection
Number of subjects: 1870
Study 33227017 — intervention group
Group type: EXPERIMENTAL
Intervention: P. falciparum combined with P. malariae
Number of subjects: 1870
Study 33227017 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall parasite density
Number of subjects: 1870
Study 33227017 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender comparison
Number of subjects: 1870
Study 35299070 — intervention group
Group type: EXPERIMENTAL
Intervention: Deutetrabenazine
Number of subjects: 295
Study 35299070 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 295
Study 32265361 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate oral etoposide
Number of subjects: 190
Study 32265361 — intervention group
Group type: COMPARATOR
Intervention: ART alone
Number of subjects: 190
Study 32265361 — intervention group
Group type: EXPERIMENTAL
Intervention: No early KS‐PD
Number of subjects: 190
Study 32265361 — intervention group
Group type: EXPERIMENTAL
Intervention: Early KS‐PD
Number of subjects: 190
Study 32265361 — intervention group
Group type: EXPERIMENTAL
Intervention: KS‐IRIS
Number of subjects: 190
Study 36057930 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics nomogram based on CT radiomic features
Number of subjects: 220
Study 36057930 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics nomogram
Number of subjects: 220
Study 36057930 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant therapy
Number of subjects: 220
Study 33423518 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure control (<140 mm Hg)
Number of subjects: 2839
Study 33423518 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of abnormal physiological parameters and warfarin use
Number of subjects: 2839
Study 35285972 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese iSupport for Dementia program (self-learning, virtual peer support, nurse program facilitator support for 6 months)
Number of subjects: 0
Study 35285972 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese iSupport for Dementia program
Number of subjects: 0
Study 35285972 — intervention group
Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 0
Study 32788479 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion giving set
Number of subjects: 215
Study 32788479 — intervention group
Group type: EXPERIMENTAL
Intervention: Burette/Soluset giving set
Number of subjects: 215
Study 32788479 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood giving set
Number of subjects: 215
Study 34781708 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilostazol (200 mg once daily for 2 years)
Number of subjects: 256
Study 34781708 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (100 mg once daily for 2 years)
Number of subjects: 256
Study 34781708 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 256
Study 34781708 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 256
Study 34482277 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative planning
Number of subjects: 320
Study 34482277 — intervention group
Group type: COMPARATOR
Intervention: Individual planning
Number of subjects: 320
Study 34482277 — intervention group
Group type: COMPARATOR
Intervention: Dyadic planning
Number of subjects: 320
Study 34482277 — intervention group
Group type: COMPARATOR
Intervention: Active (education) control
Number of subjects: 320
Study 34711261 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentalization-based parenting-counseling (MB-PC)
Number of subjects: 0
Study 34711261 — intervention group
Group type: COMPARATOR
Intervention: Enhanced standard clinical care (SCC+)
Number of subjects: 0
Study 33044838 — intervention group
Group type: EXPERIMENTAL
Intervention: Iliotibial Band (ITB) Reconstruction
Number of subjects: 16
Study 33044838 — intervention group
Group type: EXPERIMENTAL
Intervention: Achilles Tendon Reconstruction
Number of subjects: 16
Study 33044838 — intervention group
Group type: COMPARATOR
Intervention: Capsulectomy
Number of subjects: 16
Study 33044838 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconstruction (both techniques)
Number of subjects: 16
Study 36066107 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume-controlled ventilation
Number of subjects: 1224
Study 36066107 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-controlled ventilation
Number of subjects: 1224
Study 36066107 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-control with volume guaranteed ventilation
Number of subjects: 1224
Study 36066107 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1224
Study 33829990 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation (RFA)
Number of subjects: 304
Study 33829990 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple procedures (RFA)
Number of subjects: 304
Study 32083603 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive dysfunction measured at hospital discharge
Number of subjects: 109
Study 32083603 — intervention group
Group type: EXPERIMENTAL
Intervention: Social disadaptation measured at hospital discharge
Number of subjects: 109
Study 32083603 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline cognitive dysfunction
Number of subjects: 109